Merck & Co Inc (MRK)

MRK (NYSE:Drugs)
$59.88
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | MRK Avg Daily Volume: 8,126,400
Last Update: 09/17/14 - 4:01 PM EDT
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $59.88
52 Week Range: $44.62 - $61.33
Oustanding Shares: 2,884,632,033
Market Cap: 173,049,075,660
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 6 6 5
Moderate Buy 0 0 0 0
Hold 7 6 7 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.17 2.00 2.08 2.23
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
0.00 31.60 28.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.04 -0.01
Net Income -28.30 3.60 0.65
EPS -26.70 4.32 0.74
Earnings for MRK:
EBITDA 14.65B
Revenue 44.03B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.88 $0.88 $3.49 $3.61
Number of Analysts 8 7 12 11
High Estimate $0.91 $0.93 $3.53 $3.81
Low Estimate $0.86 $0.80 $3.44 $3.21
Prior Year $0.92 $0.88 $3.49 $3.49
Growth Rate (Year over Year) -4.08% 0.49% 0.07% 3.39%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Here are top names set to go ex-dividend over the next two weeks.
Update
Aug 27, 2014 | 7:14 AM EDT
Coverage of MRK was started with a Hold rating, Deutsche Bank said. Valuation call, based on a $63 price target. 
Something worrisome has me fretting more than I have in a while.

This Morning's Market Setup Real Money Pro($)

Where it began.
If you're worried about these moves, it's time to cash out.
If you don't like speculation, just hike the margin requirement.
Cisco, Merck and Intel earn approval from two rigorous stock-picking strategies.
Here are several themes that are still working -- and now you can get in at a bargain.
A wave of M&A in the health sector makes sense.
Standing still is no longer an option.

Columnist Conversations

Market gives up most of its afternoon gains after investors have time to digest comments from Federal Reserve ...
Quick service restaurant Panera Bread (PNRA) carved out a new 52-week low of $142.41 back on July 25th. It has...
My first entry in EOG ended up failing....but here's something to be aware of....IF it can clear the 106.80 ar...
Lang:
With much of the talk in Monday's drubbing about selling high beta in front of Alibaba, it seems that issue wa...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.